Navigation section

theophylline

  1. Zydus gets provisional approval from USFDA for high blood pressure drugs

    Zydus gets provisional approval from USFDA for high blood pressure drugs

    The company has received approval to market azilsartan medoxomil and chlorthalidone tablets, 40 mg/12.5 mg and 40 mg/25 mg.Azilsartan and chlorthalidone tablets are an angiotensin II receptor blocker (ARB) and thiazide-like diuretic combination product indicated for the treatment of...
    • NewsBot
    • Article
    • 1 min read
    • angiotensin approval azilsartan blood chlorthalidone company drug market medoxomil mg/12.5 mg/25 received tablets theophylline treatment
    • Category: Technology & Innovation
  2. Zydus gets USFDA nod for generic drug to treat asthma

    Zydus gets USFDA nod for generic drug to treat asthma

    New Delhi, Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market a generic product for the treatment of asthma.The company has received final approval from the US Food and Drug Administration (USFDA) for the marketing of theophylline...
    • NewsBot
    • Article
    • 1 min read
    • approval company drug extended-release generic health lifesciences market product received regulator tablets theophylline wednesday zydus
    • Category: Business & Economy
  3. Zydus Lifesciences gets USFDA nod for asthma treatment drug

    Zydus Lifesciences gets USFDA nod for asthma treatment drug

    New Delhi, Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to market generic theophylline extended-release tablets, used in the treatment of asthma and chronic obstructive pulmonary disease.The approval by the US Food and Drug Administration...
    • NewsBot
    • Article
    • 1 min read
    • approval drug extended-release final generic health lifesciences market received regulator theophylline treatment used wednesday zydus
    • Category: Business & Economy
  4. Zydus gets USFDA nod to market asthma treatment theophylline extended-release tablets

    Zydus gets USFDA nod to market asthma treatment theophylline extended-release tablets

    Theophylline is used to treat asthma and chronic obstructive pulmonary disease (COPD).The company said the US regulator has approved the sale of theophylline tablets in 300 mg and 450 mg doses.It said the drug will be manufactured at the group's formulation manufacturing facility in...
    • NewsBot
    • Article
    • 1 min read
    • annual approved asthma chronic company disease drug march obstructive pulmonary regulator sale theophylline treat used
    • Category: Technology & Innovation
Back
Top